Next Science (ASX:NXS) Interest Expense : A$-1.10 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Next Science's interest expense for the six months ended in Dec. 2023 was A$ -0.50 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$-1.10 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Next Science's Operating Income for the six months ended in Dec. 2023 was A$ -12.60 Mil. Next Science's Interest Expense for the six months ended in Dec. 2023 was A$ -0.50 Mil. Next Science did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Next Science Interest Expense Historical Data

The historical data trend for Next Science's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Interest Expense Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-3.05

-0.03

-0.02

-0.04

-1.10

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial					-0.01	-0.06	-	-0.60	-0.50

Next Science Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-1.10 Mil.

Next Science (ASX:NXS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Next Science's Interest Expense for the six months ended in Dec. 2023 was A$-0.50 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-12.60 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was A$1.03 Mil.

Next Science's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Next Science did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines